NAGOYA, Japan–(BUSINESS WIRE)–Nagoya Anesthesia Clinic (https://nagoyamasui.com/), located in Nagoya City, Aichi Prefecture, Japan, has commenced inbound medical treatment for treatment-resistant depression, post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), and intractable chronic pain, utilizing the groundbreaking drug, Ketamine, starting in October 2023. In addition, the clinic offers other innovative procedures such as Echo-Guided Botox treatment for stiff neck and EchoGuided PRP therapy for tennis elbow.
Ketamine, a widely used general anesthetic dating back to over 50 years ago, has also been employed in the United States for the treatment of mental disorders and chronic pain for the past decade. Unlike conventional medications, which can take time to alleviate symptoms, Ketamine offers rapid symptom relief within hours to up to three weeks of administration. Moreover, it is associated with minimal long-term side effects, making it a promising treatment modality.
Nagoya Anesthesia Clinic, with its rich experience of performing over 1000 Ketamine infusions for various pain and mental disorders, has launched the Ketamine Clinic based on Ketamine’s potent analgesic and antidepressant properties. Ketamine infusions are typically administered in sets of 3 to 6 sessions over a span of 1 to 3 weeks, followed by a maintenance therapy once a month, a regimen notable for its low incidence of long-term side effects.
Nagoya Anesthesia Clinic is proud to be the first and only Ketamine Clinic in Japan and will begin accepting patients for inbound medical treatment of treatment-resistant depression, OCD, PTSD, and intractable chronic pain from October 2023. Building upon their Ketamine infusion experience dating back to 2010, they aim to support individuals struggling with treatment-resistant conditions through innovative, evidence-based, and compassionate approaches.
Nagoya Anesthesia Clinic “Ketamine Clinic” Information Page:
“Stiff Neck Botox” Information Page:
“Tennis Elbow PRP Therapy” Information Page:
For inquiries, please contact:
JTB Medical & Healthcare:
The content is by Business Wire. Headlines of Today Media is not responsible for the content provided or any links related to this content. Headlines of Today Media is not responsible for the correctness, topicality or the quality of the content.